Does the influence of obesity on prognosis differ in men and women? A study of obesity paradox in patients with acute coronary syndrome

Kardiologia Polska

Volumn 73, Issue 9, 2015, Pages 761-767

  Migaj, Jacek ^a   Prokop, Edyta ^a   Straburzynska Migaj, Ewa ^a   Lesiak, Maciej ^a   Grajek, Stefan ^a   Mitkowski, Przemysław ^a  

^a Ginekologiczno Po o niczy Szpital Kliniczny im Heliodora wi cickiego Uniwersytetu Medycznego im Karola Marcinkowskiego   (Poland)

Author keywords

Acute coronary syndrome; Gender; Obesity; Outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; SPIRONOLACTONE;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OBESITY; OUTCOME ASSESSMENT; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL RATE; UNSTABLE ANGINA PECTORIS; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84941776018     PISSN: 00229032     EISSN: 18974279     Source Type: Journal    
DOI: 10.5603/KP.a2015.0087     Document Type: Article

References (26)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation, 1983;67:968-977. doi: 10.1161/01. CIR.67.5.968.
2. Aguilar MD, Lazaro P, Fitch K, Luengo S. Gender differences in clinical status at time of coronary revascularization in Spain. J Epidemiol Community Health, 2002;56:555-559.
3. Krauss MR, Winston M, Fletcher BJ, Grundy SM. Obesity: impact on cardiovascular disease. Circulation, 1998;98:1472-1476. doi: 10.1161/01. CIR.98.14.1472.
4. Grundy SM. Obesity, metabolic syndrome and coronary atherosclerosis. Circulation, 2002;105:2696-2698. doi: 10.1161/01. CIR.0000020650.86137.84.
5. McGill HC, McMahan A, Herderick EE et al. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation, 2002;105:2712-2718. doi: 10.1161/01. CIR.0000018121.67607. CE.
6. Deedwania PC. Metabolic syndrome and vascular disease. Is nature or nurture leading to new epidemic of cardiovascular disease? Circulation, 2004;109:2-4. doi: 10.1161/01. CIR.0000110642.73995. BF.
7. Oreopoulos A, Padwal R, Kalantar-Zadeh K et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J, 2008;156:13-22. doi: 10.1016/j.ahj.2008.02.014.
8. Gurm HS, Brennan DM, Booth J et al. Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox). Am J Cardiol, 2002;90:42-45.
9. Angeras O, Albertsson P, Karason K et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J, 2013;34:345-353. doi: 10.1093/eurheartj/ehs217.
10. Physical status: the use and interpretation of anthropometry Report of a WHO Expert Committee. World Health Organization, 1995;854:1-452.
11. Van De Werf F, Bax J, Betriu A et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J, 2008;29:2909-2945.
12. Hamm CW, Bassand JP, Agewall S et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011;32:2999-3054.
13. Diercks DB, Roe MT, Mulgund J et al. The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress Adverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines Quality Improvement Initiative. Am Heart J, 2006;152:141-148. doi: 10.1016/j.ahj.2005.09.024.
14. Shechter M, Hammerman H, Boyko V et al. The obesity paradox in hospitalized acute coronary syndrome patients in Israel: a National Survey. CVD Prevention Control, 2010;5:81-87. doi: 10.1016/j. cvdpc.2010.08.002.
15. Lancefield T, Clark DJ, Andrianopoulos N et al. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? J Am Coll Cardiol Intrv, 2010;3:660-668. doi: 10.1016/j. jcin. 2010.03.018.
16. Gruberg L, Weissman NJ, Waksman R et al. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? Am Coll Cardiol, 2002;39:578-584.
17. Mahaffey KW, Tonev ST, Spinler SA et al. Obesity in patients with non-ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Int J Cardiol, 2010;139:123-133. doi: 10.1016/j. ijcard.2008.10.008.
18. Kadakia MB, Fox CS, Scirica BM et al. Central obesity and cardiovascular outcomes in patients with acute coronary syndrome: observations from the MERLIN-TIMI 36 trial. Heart, 2011;97:1782-1787. doi: 10.1136/heartjnl-2011-300231.
19. Kosuge M, Kimura K, Kojima S et al. Impact of body mass index on in-hospital outcomes after percutaneous coronary intervention for ST segment elevation myocardial infarction. Circ J, 2008;72:521-525.
20. Li Y, Wu C, Sun Y et al. Obesity paradox: clinical benefits not observed in obese patients with ST-segment elevation myocardial infarction: a multicenter, prospective, cohort study of the northern region of China. Int J Cardiol, 2013;168:2949-2950. doi: 10.1016/j. ijcard.2013.03.169.
21. Kang WY, Jeong MH, Ahn YK et al. Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol, 2010;55:84-91. doi:10.1016/j.jjcc.2009.10.004.
22. Akin I, Tölg R, Hochadel M et al. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice. J Am Coll Cardiol Intv, 2012;5:162-169. doi: 10.1016/j. jcin. 2011.09.021.
23. Sarno G, Räber L, Onuma Y et al. Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents. J Am Cardiol, 2011;108:195-201. doi: 10.1016/j.amjcard.2011.03.023.
24. Schenkeveld L, Magro M, Oemrawsingh RM et al. The influence of optimal medical treatment on the 'obesity paradox', body mass index and long-term mortality in patients treated with percutaneous coronary intervention: a prospective cohort study. BMJ Open, 2012;2:e000535. doi: 10.1136/bmjopen-2011-000535.
25. Aronson D, Nassar M, Goldberg T et al. The impact of body mass index on clinical outcomes after acute myocardial infarction. Int J Cardiol, 2010;145:476-480. doi: 10.1016/j.ijcard.2009.12.029.
26. Byrne J, Spence MS, Fretz E et al. Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). Am J Cardiol, 2009;103:507-511.